Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.

Dendritic cells (DCs) are exceptionally potent antigen-presenting cells (APCs) in the human body and are considered the “sentinels” of the immune system. They are essential in establishing, ...

Cancer has a talent for hiding in plain sight, cloaking itself in sugary molecules that convince the immune system to stand ...

Cancer immunotherapy is a strategy that turns the patient's own immune cells into a "search-and-destroy" force that attacks the tumor's cells. The ...

Image : F. Duval, UNIGE. Immune hubs within tumors can either strengthen the body’s antitumor response or silently dampen it. These structures form in close proximity to blood vessels (pink, ...

A new study has revealed that a special group of cells in the intestines tamp down the immune responses caused by exposure to food proteins. Called 'tolerogenic dendritic cells,' these cells enable ...

Engineering dendritic cells to better identify cancer cells and trigger precise immune responses may boost immunotherapy.